TBA Eli Lilly Australia Pty Ltd

NEXVOUND (orforglipron calcium) is proposed as a therapy to support weight loss and long‑term weight management. It is intended to be used alongside a healthy diet and regular physical activity in adults with obesity, or in adults who are overweight and have at least one other weight‑related condition. It is also proposed as treatment in adults with type 2 diabetes mellitus alongside a healthy diet and physical activity.